Enrolling Clinical Research Studies

Acne Vulgaris

Moderate to Severe Endometriosis-Associated Pain

Moderately to Severely Active Crohn’s Disease

Celiac Disease on a Gluten Free Diet

Hot Flashes

Menstrual Bleeding Associated with Uterine Fibroids

Moderately to Severely Active Ulcerative Colitis

Monoclonal Antibody Treatment for COVID-19

NASH

TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS (FLU)

Treatment of COVID-19 in an Outpatient Setting

Treatment Trial for Outpatients with COVID-19

Treatment Trial for Outpatients with COVID-19

Uncontrolled Asthma

Urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infect

Dermatology
 Treatment for Acne Vulgaris

Treatment for Acne Vulgaris

Acne is the most common skin disease in the US and affects 80% of the population at some point in life.

» Study Details | Apply for the Study

Future Studies
Upcoming Studies for Men & Women

Upcoming Studies for Men & Women

Click to add your name to the waiting list for upcoming studies. We will alert you when we begin a new study. Please provide your email address if possible.

*PLEASE DO NOT CALL THE STUDY CENTER UNLESS YOU ARE CONTACTED FIRST*

» Study Details | Apply for the Study

Gastroenterology
Celiac Disease on a Gluten Free Diet

Celiac Disease on a Gluten Free Diet

If you are experiencing celiac disease symptoms despite following a gluten-free diet, you may want to talk to your doctor about our clinical study.

» Study Details | Apply for the Study

Ulcerative Colitis Study

Ulcerative Colitis Study

A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants with Moderately to Severely Active Ulcerative Colitis

» Study Details | Apply for the Study

Moderately to Severely Active Crohn’s Disease

Moderately to Severely Active Crohn’s Disease

A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-Controlled, Operationally Seamless Phase 2b/3, Parallel-group Study to Assess the Efficacy and Safety of Brazikumab in Participants with Moderately to Severely Active Crohn’s Disease

» Study Details | Apply for the Study

Non-Alcoholic Steatohepatitis (NASH)

Non-Alcoholic Steatohepatitis (NASH)

A Phase 2b Randomized, Double Blind, Placebo-Controlled, Multicenter Study Evaluating Safety and Efficacy of EDP-305 in Subjects with Liver-Biopsy Proven Non-Alcoholic Steatohepatitis (NASH)

» Study Details | Apply for the Study

Women’s Health
Moderate to Severe Endometriosis-Associated Pain

Moderate to Severe Endometriosis-Associated Pain

Endometriosis is a chronic oestrogen-dependent condition characterised by the growth of endometrial tissue in sites other than the uterine cavity, most commonly the pelvic cavity (including the ovaries), the uterosacral ligaments, the pouch of Douglas, the rectosigmoid colon, and the bladder and distal ureter

» Study Details | Apply for the Study

 

heavy menstrual bleeding associated with uterine fibroids in premenopausal

Heavy Menstrual Bleeding Associated with Uterine Fibroids

» Study Details | Apply for the Study

Hot Flashes Associated with Menopause

Hot Flashes Associated with Menopause

Moderate to Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause

» Study Details | Apply for the Study

ID
COVID-19 Treatment Clinical Trial

COVID-19 Treatment Clinical Trial

A Phase 3 Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of COVID-19 in an Outpatient Setting

» Study Details | Apply for the Study

Phase 3 double-blind placebo-controlled efficacy tPrevention of urogenital

Phase 3 double-blind placebo-controlled efficacy tPrevention of urogenital

Vaginal gel for the prevention of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection

» Study Details | Apply for the Study

Monoclonal Antibody Treatment for COVID-19

Monoclonal Antibody Treatment for COVID-19

Adapt Out COVID is a master protocol to evaluate the safety and efficacy of investigational agents for the treatment of symptomatic non-hospitalized adults with COVID-19. A larger phase III evaluation for promising agents (Monoclonal Antibody)

» Study Details | Apply for the Study

Adaptive Platform Treatment Trial for Outpatients with COVID-19

Adaptive Platform Treatment Trial for Outpatients with COVID-19

Adaptive Platform Treatment Trial for Outpatients with COVID-19

» Study Details | Apply for the Study

COVID-19 Treatment Clinical Trial

COVID-19 Treatment Clinical Trial

Study to Evaluate the Efficacy and Safety of CT P59 in Combination with Standard of Care in Outpatients with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) Infection

» Study Details | Apply for the Study

 

TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS

A PHASE 2B DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF NORKETOTIFEN IN THE TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS (ILI)

» Study Details | Apply for the Study

Allergy & Asthma
Severe uncontrolled asthma with an eosinophilic phenotype

Severe uncontrolled asthma with an eosinophilic phenotype

Severe Uncontrolled Asthma With An Eosinophilic Phenotype

» Study Details | Apply for the Study

Powered By RealTime-CTMS Clinical Trial Management System